BGI

B Group Inc Portfolio holdings

AUM $135M
1-Year Est. Return 80%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+80%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$135M
AUM Growth
-$61.2K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$11.8M
3
+$6.06M
4
DRUG
Bright Minds Biosciences
DRUG
+$5.43M
5
GPCR icon
Structure Therapeutics
GPCR
+$2.57M

Top Sells

1
+$908K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
1
ADMA Biologics
ADMA
$1.8B
$28.9M 21.43%
3,207,542
+750,000
PALI icon
2
Palisade Bio
PALI
$335M
$20M 14.81%
11,414,285
+6,914,285
PRAX icon
3
Praxis Precision Medicines
PRAX
$7.77B
$10.7M 7.94%
33,237
CLLS
4
Cellectis
CLLS
$310M
$10.4M 7.71%
3,281,501
ZLAB icon
5
Zai Lab
ZLAB
$1.93B
$8.48M 6.28%
450,646
+50,646
TSHA icon
6
Taysha Gene Therapies
TSHA
$1.59B
$8.05M 5.97%
1,800,556
NRXP icon
7
NRX Pharmaceuticals
NRXP
$146M
$6.39M 4.74%
+3,000,000
GPCR icon
8
Structure Therapeutics
GPCR
$2.67B
$6.15M 4.56%
127,500
+37,500
IOVA icon
9
Iovance Biotherapeutics
IOVA
$1.69B
$5.26M 3.9%
1,500,000
SYRE icon
10
Spyre Therapeutics
SYRE
$6.38B
$5.04M 3.74%
100,000
DRUG
11
Bright Minds Biosciences
DRUG
$729M
$4.93M 3.65%
+67,500
ASMB icon
12
Assembly Biosciences
ASMB
$483M
$4.88M 3.61%
175,706
AURA icon
13
Aura Biosciences
AURA
$711M
$4M 2.96%
597,576
+25,000
ORKA
14
Oruka Therapeutics
ORKA
$3.45B
$3.68M 2.73%
75,000
SGHT icon
15
Sight Sciences
SGHT
$236M
$3.66M 2.71%
970,000
+50,000
RARE icon
16
Ultragenyx Pharmaceutical
RARE
$2.21B
$2.83M 2.1%
135,000
APGE icon
17
Apogee Therapeutics
APGE
$6.35B
$631K 0.47%
7,500
-12,500
FHTX icon
18
Foghorn Therapeutics
FHTX
$213M
$488K 0.36%
+102,000
SLNO
19
DELISTED
Soleno Therapeutics
SLNO
$251K 0.19%
+7,500
REPL icon
20
Replimune Group
REPL
$823M
$199K 0.15%
+26,000